Ledger.Open graph →
SEC Form D · filed January 22, 2026

NBO Pharma Inc

Offering
$7.6M
Sold
$7.6M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
BEDFORD, NY
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (4)

Colin D. Foster · Woodbridge, CTDirectorFredric D. Price · Bedford, NYExec · DirectorRobert D. Friedman · Teaneck, NJDirectorBard D. Geesaman · Marlboro, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗